Table of Contents
ISRN Oncology
Volume 2012 (2012), Article ID 706162, 4 pages
http://dx.doi.org/10.5402/2012/706162
Review Article

Treatment Options for Metaplastic Breast Cancer

Division of Surgical Oncology, UC Davis Comprehensive Cancer, Sacramento, CA 95817, USA

Received 11 April 2012; Accepted 21 May 2012

Academic Editors: P. Clavère, P. Karakitsos, M. Mandala, and C. Perez

Copyright © 2012 Dhruvil R. Shah et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. A. Oberman, “Metaplastic carcinoma of the breast. A clinicopathologic study of 29 patients,” American Journal of Surgical Pathology, vol. 11, no. 12, pp. 918–929, 1987. View at Google Scholar · View at Scopus
  2. E. S. Wargotz and H. J. Norris, “Metaplastic carcinomas of the breast. I. Matrix-producing carcinoma,” Human Pathology, vol. 20, no. 7, pp. 628–635, 1989. View at Google Scholar · View at Scopus
  3. E. S. Wargotz, P. H. Deos, and H. J. Norris, “Metaplastic carcinomas of the breast. II. Spindle cell carcinoma,” Human Pathology, vol. 20, no. 8, pp. 732–740, 1989. View at Google Scholar · View at Scopus
  4. E. S. Wargotz and H. J. Norris, “Metaplastic carcinomas of the breast. III. Carcinosarcoma,” Cancer, vol. 64, no. 7, pp. 1490–1499, 1989. View at Google Scholar · View at Scopus
  5. E. S. Wargotz and H. J. Norris, “Metaplastic carcinomas of the breast. IV. Squamous cell carcinoma of ductal origin,” Cancer, vol. 65, no. 2, pp. 272–276, 1990. View at Publisher · View at Google Scholar · View at Scopus
  6. E. S. Wargotz and H. J. Norris, “Metaplastic carcinomas of the breast: V. Metaplastic carcinoma with osteoclastic giant cells,” Human Pathology, vol. 21, no. 11, pp. 1142–1150, 1990. View at Publisher · View at Google Scholar · View at Scopus
  7. F. A. Tavassoli, “Classification of metaplastic carcinomas of the breast,” Pathology Annual, vol. 27, part 2, pp. 89–119, 1992. View at Google Scholar · View at Scopus
  8. C. M. Pezzi, L. Patel-Parekh, K. Cole, J. Franko, V. S. Klimberg, and K. Bland, “Characteristics and treatment of metaplastic breast cancer: analysis of 892 cases from the national cancer data base,” Annals of Surgical Oncology, vol. 14, no. 1, pp. 166–173, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. P. J. Barnes, R. Boutilier, D. Chiasson, and D. Rayson, “Metaplastic breast carcinoma: clinical-pathologic characteristics and HER2/neu expression,” Breast Cancer Research and Treatment, vol. 91, no. 2, pp. 173–178, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Luini, M. Aguilar, G. Gatti et al., “Metaplastic carcinoma of the breast, an unusual disease with worse prognosis: the experience of the European Institute of Oncology and review of the literature,” Breast Cancer Research and Treatment, vol. 101, no. 3, pp. 349–353, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. D. Rayson, A. A. Adjei, V. J. Suman, L. E. Wold, and J. N. Ingle, “Metaplastic breast cancer: prognosis and response to systemic therapy,” Annals of Oncology, vol. 10, no. 4, pp. 413–419, 1999. View at Publisher · View at Google Scholar · View at Scopus
  12. M. M. Poggi, D. N. Danforth, L. C. Sciuto et al., “Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy: the National Cancer Institute randomized trial,” Cancer, vol. 98, no. 4, pp. 697–702, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. W. H. Tseng and S. R. Martinez, “Metaplastic breast cancer: to radiate or not to radiate?” Annals of Surgical Oncology, vol. 18, no. 1, pp. 94–103, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. G. R. Gibson, D. Qian, J. K. Ku, and L. L. Lai, “Metaplastic breast cancer: clinical features and outcomes,” American Surgeon, vol. 71, no. 9, pp. 725–730, 2005. View at Google Scholar · View at Scopus
  15. G. Dave, H. Cosmatos, T. Do, K. Lodin, and D. Varshney, “Metaplastic carcinoma of the breast: a retrospective review,” International Journal of Radiation Oncology Biology Physics, vol. 64, no. 3, pp. 771–775, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. A. E. Giuliano, D. M. Kirgan, J. M. Guenther, and D. L. Morton, “Lymphatic mapping and sentinel lymphadenectomy for breast cancer,” Annals of Surgery, vol. 220, no. 3, pp. 391–401, 1994. View at Google Scholar · View at Scopus
  17. A. E. Giuliano, K. K. Hunt, K. V. Ballman et al., “Axillary dissection versus no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial,” Journal of the American Medical Association, vol. 305, no. 6, pp. 569–575, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. J. D. Beatty, M. Atwood, R. Tickman, and M. Reiner, “Metaplastic breast cancer: clinical significance,” American Journal of Surgery, vol. 191, no. 5, pp. 657–664, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. B. T. Hennessy, S. Giordano, K. Broglio et al., “Biphasic metaplastic sarcomatoid carcinoma of the breast,” Annals of Oncology, vol. 17, no. 4, pp. 605–613, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Y. Bae, S. K. Lee, M. Y. Koo et al., “The prognoses of metaplastic breast cancer patients compared to those of triple-negative breast cancer patients,” Breast Cancer Research and Treatment, vol. 126, no. 2, pp. 471–478, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. T. Sørlie, “Molecular portraits of breast cancer: tumour subtypes as distinct disease entities,” European Journal of Cancer, vol. 40, no. 18, pp. 2667–2675, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. L. A. Carey, E. C. Dees, L. Sawyer et al., “The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes,” Clinical Cancer Research, vol. 13, no. 8, pp. 2329–2334, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Leibl and F. Moinfar, “Metaplastic breast carcinomas are negative for Her-2 but frequently express EGFR (Her-1): potential relevance to adjuvant treatment with EGFR tyrosine kinase inhibitors?” Journal of Clinical Pathology, vol. 58, no. 7, pp. 700–704, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. U. Brown-Glaberman, A. Graham, and A. Stopeck, “A case of metaplastic carcinoma of the breast responsive to chemotherapy with ifosfamide and etoposide: improved antitumor response by targeting sarcomatous features,” Breast Journal, vol. 16, no. 6, pp. 663–665, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. H. Gutman, R. E. Pollock, N. A. Janjan, and D. A. Johnston, “Biologic distinctions and therapeutic implications of sarcomatoid metaplasia of epithelial carcinoma of the breast,” Journal of the American College of Surgeons, vol. 180, no. 2, pp. 193–199, 1995. View at Google Scholar · View at Scopus
  26. M. Clarke, R. Collins, S. Darby et al., “Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials,” The Lancet, vol. 366, no. 9503, pp. 2087–2106, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. J. Ragaz, S. M. Jackson, N. Le et al., “Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer,” New England Journal of Medicine, vol. 337, no. 14, pp. 956–962, 1997. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Overgaard, P. S. Hansen, J. Overgaard et al., “Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy,” New England Journal of Medicine, vol. 337, no. 14, pp. 949–955, 1997. View at Publisher · View at Google Scholar · View at Scopus
  29. B. Fowble, R. Gray, K. Gilchrist, R. L. Goodman, S. Taylor, and D. C. Tormey, “Identification of a subgroup of patients with breast cancer and histologically positive axillary nodes receiving adjuvant chemotherapy who may benefit from postoperative radiotherapy,” Journal of Clinical Oncology, vol. 6, no. 7, pp. 1107–1117, 1988. View at Google Scholar · View at Scopus